Exagen Inc. (XGN) Financials

XGN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 52.0 million 37.5 million
Dec. 31, 2025 58.0 million 40.6 million
Sept. 30, 2025 62.8 million 44.7 million
June 30, 2025 58.8 million 37.7 million

XGN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -10.6 million 655000
Dec. 31, 2025 -3.1 million 705000
Sept. 30, 2025 2.7 million 593000
June 30, 2025 -3.1 million 443000

XGN Net Income

No data available :(

XGN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 21.5 million 1.9 million -
Dec. 31, 2025 32.2 million 22.3 million 2.4 million
Sept. 30, 2025 35.7 million 22.3 million 2.9 million
June 30, 2025 30.0 million 22.3 million 2.2 million

XGN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 23.9 million
Dec. 31, 2025 21.6 million
Sept. 30, 2025 22.9 million
June 30, 2025 21.1 million

XGN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 228000 1.6 million 12.1 million -
Dec. 31, 2025 44000 1.8 million 12.4 million -
Sept. 30, 2025 275000 1.7 million 11.4 million -
June 30, 2025 209000 1.5 million 11.5 million -

XGN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 17.3 million 7.1 million
Dec. 31, 2025 16.6 million 7.4 million
Sept. 30, 2025 17.2 million 7.2 million
June 30, 2025 17.2 million 6.8 million

XGN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

XGN

Price: $4.29

52 week price:
2.59
12.23

Earnings Per Share: -0.90 USD

Exchange: NGM

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 10300

Market Capitalization: 87.9 million

Links: